Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Emergent BioSolutions Inc. (EBS)

63.33   -0.39 (-0.61%) 02-22 16:02
Open: 66.1 Pre. Close: 63.72
High: 67.45 Low: 62.04
Volume: 716,334 Market Cap: 3226M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 67.551 - 68.023 68.023 - 68.386
Low: 60.876 - 61.479 61.479 - 61.943
Close: 62.486 - 63.312 63.312 - 63.946

Technical analysis

as of: 2019-02-22 4:41:50 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 78.78     One year: 92.02
Support: Support1: 61.89    Support2: 58.46
Resistance: Resistance1: 67.45    Resistance2: 78.78
Pivot: 64.17
Moving Average: MA(5): 64.80     MA(20): 63.25
MA(100): 63.81     MA(250): 58.29
MACD: MACD(12,26): 0.69     Signal(9): 0.67
Stochastic oscillator: %K(14,3): 55.23     %D(3): 71.58
RSI: RSI(14): 49.49
52-week: High: 73.89  Low: 46.93  Change(%): 31.5
Average Vol(K): 3-Month: 40865  10-Days: 32262

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EBS has closed above bottom band by 33.2%. Bollinger Bands are 46.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to EBS's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 22 Feb 2019 18:09:28 Z
Emergent (EBS) Q4 Earnings, Revenues Surpass Estimates

Fri, 22 Feb 2019 04:10:05 Z
Emergent Biosolutions Inc (EBS) Q4 2018 Earnings Conference Call Transcript

Fri, 22 Feb 2019 03:15:27 Z
Emergent Biosolutions (EBS) Q4 Earnings and Revenues Surpass Estimates

Thu, 14 Feb 2019 17:44:15 Z
Earnings Preview: Emergent Biosolutions (EBS) Q4 Earnings Expected to Decline

Wed, 09 Jan 2019 00:42:01 Z
Emergent (EBS) Up on '19 View, Posts Preliminary '18 Results

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 50.95
Shares Float (M) 48.75
% Held by Insiders
% Held by Institutions 127.40
Shares Short (K) 2935
Shares Short P. Month (K)

Stock Financials

EPS 2.330
EPS Est. Current Year 1.540
EPS Est. Next Year 2.260
EPS Est. Next Quarter 0.710
Forward EPS 2.759
Book Value (p.s.) 3.440
PEG Ratio 2.84
Profit Margin 12.93
Operating Margin 19.11
Return on Assets (ttm) 9.1
Return on Equity (ttm) 12.3
Qtrly Rev. Growth 16.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -37.60
Operating Cash Flow (M) 285.09
Levered Free Cash Flow (M) 106.49

Stock Valuations

P/E 27.18
P/E Growth Ratio -0.01
P/BV 18.41
P/S 221611504.00
P/CF 11.32

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.